2024-11-09 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Analysis Report

**1. Performance Comparison:**

Teladoc Health Inc (TDOC) has underperformed the S&P 500 (VOO) significantly, with a cumulative return of 53.9% compared to 140.24% for the S&P 500. The current **cumulative return difference is -86.34%**, placing it in the **0th percentile** of historical performance relative to the S&P 500.

**Company Overview:** Teladoc Health is a leading provider of telehealth services, connecting patients with medical professionals virtually.

**Alpha & Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|---|---|---|---|---|
| 2015-2017 | 83.4% | 54.5% | 53.2% | 1.3 |
| 2016-2018 | 175.5% | 46.7% | 150.9% | 1.7 |
| 2017-2019 | 407.4% | 46.7% | 364.3% | 1.8 |
| 2018-2020 | 452.4% | 46.7% | 413.3% | 0.6 |
| 2019-2021 | 90.6% | 55.8% | 0.8% | 0.5 |
| 2020-2022 | -71.6% | 61.0% | -89.3% | 0.8 |
| 2021-2023 | -89.3% | 64.9% | -118.1% | 2.0 |
| 2022-2024 | -90.0% | 45.9% | -114.6% | 2.0 |

TDOC has exhibited high growth potential in the past but has recently experienced significant declines. While beta has fluctuated, it generally suggests higher volatility compared to the broader market.

**2. Recent Price Movement:**

* Closing price: $9.51 (Last-market: $9.24)
* 5-day moving average: $9.24
* 20-day moving average: $9.16
* 60-day moving average: $8.4

The stock price has been relatively stable in the short term, hovering around its 5-day and 20-day moving averages, suggesting possible consolidation.

**3. Technical Indicators:**

* RSI: 45.33 (Neutral)
* PPO: 0.12 (Neutral)
* Delta_Previous_Relative_Divergence: -1.04 (Short-term Downward Trend)
* Expected Return: 0.0% (Long-term Expected Return)

While RSI and PPO are neutral, the Delta_Previous_Relative_Divergence indicates a short-term downward trend. The 0% expected return suggests that long-term (2+ years) investment in TDOC is likely to yield returns similar to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-31 | -0.19 | $0.64 B |
| 2024-08-01 | -4.92 | $0.64 B |
| 2024-04-26 | -0.49 | $0.65 B |
| 2023-10-27 | -0.35 | $0.66 B |
| 2024-10-31 | -0.35 | $0.66 B |

The most recent earnings (2024-10-31) show a continued decline in EPS, although revenue remains relatively stable. Analyst expectations are not provided here.

**5. Financial Information:**

* **Revenue and Profitability:**
    * Revenue has remained stable, showing consistent performance.
    * Profit margins are high, demonstrating a profitable business model.
* **Capital and Profitability:**
    * Equity is relatively stable, indicating financial stability.
    * ROE has been fluctuating, reflecting the recent decline in earnings and challenging market conditions.

**6. News and Recent Issues:**

* No recent earnings news was found.
* **Market Outlook:**  Recent market analysis has been mixed. Some sources suggest potential for recovery due to the company's strong market position and potential for growth in telehealth. However, others highlight ongoing financial challenges and competition in the industry.
* **Analyst Opinions:** Analyst ratings have been mixed, ranging from "Hold" to "Strong Buy." Performance highlights include a decline in revenue growth but still strong market share.
* **Recent Issues:**  TDOC has been grappling with recent financial losses, a challenging market environment, and increasing competition from other telehealth providers. However, the company continues to invest in growth initiatives and expand its offerings.

**7. Comprehensive Analysis:**

* TDOC has experienced a significant decline in performance compared to the S&P 500, despite exhibiting strong growth in the past.
* The stock is currently consolidating around its moving averages, with technical indicators suggesting mixed signals.
* Recent earnings show a continued decline in EPS, while revenue remains stable.
* Despite financial challenges, TDOC operates in a high-growth market with a strong market position and potential for future growth.

**8. Conclusion:**

Teladoc Health Inc (TDOC) presents a mixed picture. While the company faces challenges, it also holds potential for future growth in the telehealth sector. Investors should carefully evaluate their risk tolerance and investment horizon before making any decisions. Long-term investors who are willing to ride out potential volatility could find value in TDOC at its current valuation. However, those seeking immediate returns or a guaranteed win might be better served by exploring other investment opportunities. 
